CIK 0001704287
- Emerging growth company
Bluejay Diagnostics, Inc.
Sign in to watch- Ticker
- BJDX
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473552922
- Phone
- +1 978-631-0152
- Business address
- 360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, MA, 01720
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Fisher Kenneth R Chief Financial Officer | Grant or award | +112,500 | $0.44 | $50K | 152,500 |
| 2023-02-01 | Fisher Kenneth R Chief Financial Officer | Shares withheld for taxes | −39,316 | $0.44 | $17K | 113,184 |
| 2022-08-26 | Fisher Kenneth R Chief Financial Officer | Purchase | +20,000 | $1.03 | $21K | 40,000 |
| 2022-04-25 | Fisher Kenneth R Chief Financial Officer | Purchase | +20,000 | $0.99 | $20K | 20,000 |
| 2022-03-23 | Fisher Kenneth R Chief Financial Officer | Grant or award · Option (right to buy) | +65,000 | 65,000 |
Page 1 of 1 · 5 trades